ARBOR PHARMACEUTICALS, LLC: Confirms Availability of Triptodur® (triptorelin) for Patients with Central Precocious Puberty
Company orders additional product amid reported industry shortage Read More »
Physician groups recommend topical NSAIDs for acute pain
For patients with non-low back, musculoskeletal injuries, non-steroidal anti-inflammatory drugs should be a first-line treatment for acute pain that lasts no more than four weeks, according to a new guideline from the American College of Physicians and the American Academy of Family Physicians. Read More »
Cost of sharing assistance program threatened by administration actions
The high costs of medical care are well-documented, but those battling significant illnesses have found a measure of economic relief through manufacturer cost-sharing assistance programs. Read More »
PhRMA exec optimistic on COVID-19 vaccine
The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »
AAM: Generic, biosimilar medicines help keep Americans healthy
In a recent response to President Donald Trump's executive order regarding essential medicines, the Association for Accessible Medicines highlighted the importance of generic and biosimilar medicines for ensuring the health and well-being of U.S. residents. Read More »
KARMANOS CANCER INSTITUTE: Karmanos Specialty Pharmacy (KSP) receives full, three-year accreditation from the Utilization Review Accreditation Commission (URAC)
Karmanos Specialty Pharmacy (KSP) is pleased to announce that it has received full accreditation from the Utilization Review Accreditation Commission (URAC). This accreditation is valid for three years. Read More »
TOLMAR: Affirms Supply of FENSOLVI® (leuprolide acetate) for Pediatric Patients with Central Precocious Puberty
Company increases U.S. manufacturing capacity of drug to ensure uninterrupted supply amid industry shortage Read More »
AHA releases best practices for cardiovascular disease
The best practices for genetic testing for the management of cardiovascular diseases that are inherited have been outlined by the American Heart Association (AHA). Read More »
Health care organizations call for Congress to recognize pharmacists as providers of billable services
A recent letter to Congressional leaders from a coalition headed by the National Forum for Heart Disease and Stroke Prevention urges Congress to include payments for front-line pharmacists in the next COVID-19 relief package by designating them as providers under Medicare Part B. Read More »
MEDLY PHARMACY: Expands Digital Pharmacy Services Into Baltimore
Medly Continues Nationwide Expansion With the Launch of Digital Pharmacy Services, Including Free, Same-Day Delivery, Into the Baltimore Market Read More »
APHA: Transparency, Safety and Availability Must Be Core Principles for Strengthening America's Drug Supply Chain
The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Read More »
PHARMACY QUALITY SOLUTIONS: Announces Appointment of John Michael O’Brien to Board of Directors
PQS adds former Senior Advisor to the Secretary for Drug Pricing Reform, U.S. Department of Health and Human Services to its Board of Directors Read More »
HUMANA: Ranks #1 for Customer Satisfaction for Mail Order in J.D. Power Pharmacy Study for Third Year in a Row
Humana Pharmacy, a division of Humana Inc. (NYSE: HUM), has been named the best in Mail Order Pharmacy customer satisfaction in the J.D. Power 2020 U.S. Pharmacy Study. It’s the third consecutive year that Humana has received the prestigious honor. Read More »
John Hopkins study seeks solution for cardiovascular complications of people living with HIV
A recent pilot study conducted by Johns Hopkins Medicine may show promise for lowering cholesterol in some patients by using a drug that inhibits a protein involved in cholesterol metabolism. Read More »
AEI expert calls for coordinated world effort to distribute COVID-19 vaccine
James Capretta, a resident fellow and health analyst with the American Enterprise Institute (AEI), a Washington D.C.-based think tank that researches government, economics and social welfare, called for a coordinated effort to distribute vaccine worldwide to prevent COVID-19 infection. Read More »
Biopharmaceutical industry reports over 400 medicines, vaccines in development
A recent report by the biopharmaceutical industry shows that there are over 400 medicines and vaccines in development to treat infectious diseases, including COVID-19, according to a news release by PhRMA. Read More »
Grein: Those suffering from COVID-19 receiving experimental treatments
The majority receiving COVID-19 experimental treatments are those patients hospitalized with the coronavirus, Cedars-Sinai Hospital Epidemiology Director Jonathan Grein said in a recent news release. Read More »
AGENUS: Receives $35M In Immuno-Oncology Transaction with Betta Pharmaceuticals
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with an extensive pipeline of agents designed to activate immune response to cancers, announced the closing of a $20 million equity investment, at $4.03 per share, by Betta Pharmaceuticals (SZ300558) bringing the total received to $35M. Read More »
LANNETT: To Launch Levorphanol Tablets
Signs Exclusive U.S. Distribution Agreement with Novitium Pharma Read More »
States are using the health care system to battle opioid use disorder
To control the opioid crisis, states are developing programs within the health care system to fight opioid use disorder (OUD) by increasing both the access to and quality of available treatment for those afflicted. Read More »
Alerts Sign-up